ATE226814T1 - Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff - Google Patents

Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff

Info

Publication number
ATE226814T1
ATE226814T1 AT96919786T AT96919786T ATE226814T1 AT E226814 T1 ATE226814 T1 AT E226814T1 AT 96919786 T AT96919786 T AT 96919786T AT 96919786 T AT96919786 T AT 96919786T AT E226814 T1 ATE226814 T1 AT E226814T1
Authority
AT
Austria
Prior art keywords
flavor
pharmaceutical composition
active ingredient
composition produced
produced
Prior art date
Application number
AT96919786T
Other languages
English (en)
Inventor
Philip Christopher Buxton
Janice Duncan
Wendy Johnson
Geoffrey David Tovey
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9510349.5A external-priority patent/GB9510349D0/en
Priority claimed from GBGB9604187.6A external-priority patent/GB9604187D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE226814T1 publication Critical patent/ATE226814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
AT96919786T 1995-05-23 1996-05-15 Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff ATE226814T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9510349.5A GB9510349D0 (en) 1995-05-23 1995-05-23 Formulations
GBGB9604187.6A GB9604187D0 (en) 1996-02-28 1996-02-28 Flavouring system
PCT/EP1996/002144 WO1996037188A1 (en) 1995-05-23 1996-05-15 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament

Publications (1)

Publication Number Publication Date
ATE226814T1 true ATE226814T1 (de) 2002-11-15

Family

ID=26307069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919786T ATE226814T1 (de) 1995-05-23 1996-05-15 Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff

Country Status (17)

Country Link
US (1) US6428808B1 (de)
EP (1) EP0827393B1 (de)
JP (1) JP4128622B2 (de)
KR (1) KR19990021841A (de)
CN (1) CN1190887A (de)
AT (1) ATE226814T1 (de)
AU (1) AU5819296A (de)
BR (1) BR9609051A (de)
CA (1) CA2219824A1 (de)
CZ (1) CZ369297A3 (de)
DE (1) DE69624563T2 (de)
ES (1) ES2185776T3 (de)
HU (1) HUP9802302A2 (de)
NO (1) NO975371D0 (de)
PL (1) PL323496A1 (de)
TR (1) TR199701410T1 (de)
WO (1) WO1996037188A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU708501B3 (en) * 1998-09-04 1999-08-05 Australian Medical Research Centre Medication administration means and method of administering medication
US20050112241A1 (en) * 2003-10-28 2005-05-26 Steven Catani Filter with sweetener
US7371405B2 (en) * 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms
US20050136105A1 (en) * 2003-12-22 2005-06-23 Allen Marni L. Consumer customized dosage forms
US20070172552A1 (en) * 2006-01-17 2007-07-26 Davies Gary R Sweet-tea
US20090287144A1 (en) * 2007-02-15 2009-11-19 Kidkupz Llc Pediatric medicine dosage cup, tray, and fabrication method
WO2010096058A1 (en) * 2009-02-20 2010-08-26 Kidkupz Llc Pediatric medicine dosage cup, tray, and fabrication method
JP6896431B2 (ja) * 2017-01-10 2021-06-30 株式会社Ｓｃｒｅｅｎホールディングス 粒状物、読取装置、および印刷装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071614A (en) * 1975-06-03 1978-01-31 Colgate Palmolive Company Dentifrice containing encapsulated flavoring
US4292028A (en) 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
EP0086428B1 (de) * 1979-08-23 1987-07-29 Beecham Group Plc Veterinärmittel gegen Diarrhöe, seine Herstellung und dieses enthaltende orale Dosierungsvorrichtung
IT1204069B (it) 1986-05-30 1989-03-01 Menarini Sas Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
FR2686064B1 (fr) 1992-01-15 1995-04-21 Remy Deslandes Conteneur pour la consommation d'une dose de produit liquide.
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US5560912A (en) * 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
DE69622542T2 (de) * 1996-01-04 2003-05-08 Smithkline Beecham Corp., King Of Prussia Substituierte benzopyrane
GB9700331D0 (en) * 1997-01-09 1997-02-26 Smithkline Beecham Plc Process
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative

Also Published As

Publication number Publication date
HUP9802302A2 (hu) 1999-02-01
NO975371L (no) 1997-11-21
BR9609051A (pt) 1999-02-23
JPH11505816A (ja) 1999-05-25
EP0827393A1 (de) 1998-03-11
WO1996037188A1 (en) 1996-11-28
DE69624563D1 (de) 2002-12-05
ES2185776T3 (es) 2003-05-01
KR19990021841A (ko) 1999-03-25
MX9709001A (es) 1998-03-31
PL323496A1 (en) 1998-03-30
DE69624563T2 (de) 2003-06-18
US6428808B1 (en) 2002-08-06
EP0827393B1 (de) 2002-10-30
CA2219824A1 (en) 1996-11-28
TR199701410T1 (xx) 1998-03-21
AU5819296A (en) 1996-12-11
CN1190887A (zh) 1998-08-19
CZ369297A3 (cs) 1998-05-13
NO975371D0 (no) 1997-11-21
JP4128622B2 (ja) 2008-07-30

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
DE3860550D1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0015188A (pt) Composições farmacêuticas
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
HK1046527A1 (zh) 金剛烷衍生物
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE3483508D1 (de) Physiologisch aktive substanz k-252, verfahren zu ihrer herstellung und eine pharmazeutische zusammensetzung die diese enthaelt.
CA2280310A1 (en) Nmda antagonist
IL150528A0 (en) Ibuprofen containing active agent preparation
IE882391L (en) Pad printing process
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE226814T1 (de) Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
KR880007060A (ko) 제약 조성물
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
ES2170649B1 (es) Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties